Skip to content

FDA grants accelerated approval to iberdomide combo in multiple myeloma
Post-transplantation outcomes have improved for Hodgkin lymphoma
Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome
NICE recommends acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukemia
FDA approves subcutaneous isatuximab-irfc for multiple myeloma

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Saad Usmani, MD

Cellular Therapy

Saad Usmani, MD

Leukemia

Saad Usmani, MD

Lymphoma

Saad Usmani, MD

Multiple Myeloma

Saad Usmani, MD

Myelodysplastic Syndromes

Saad Usmani, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

August 15, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Saad Usmani, MD

Saad Usmani, MD

by sohonews
January 31, 2025
0 Comments
Less than a minute
795 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

FDA

Multiple Myeloma, News

FDA grants accelerated approval to iberdomide combo in multiple myeloma

August 14, 2026

cancer cells

Cellular Therapy, Lymphoma

Post-transplantation outcomes have improved for Hodgkin lymphoma

August 13, 2026

ASCO 2026, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Video Interviews

Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome

August 11, 2026

older adult patient

News

NICE recommends acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukemia

August 10, 2026

FDA laptop

Multiple Myeloma, News

FDA approves subcutaneous isatuximab-irfc for multiple myeloma

August 10, 2026

EHA 2026, Lymphoma, Aggressive B-Cell Lymphomas, Video Interviews

Drs. George Lenz and Loretta Nastoupil discuss phase 3 FRONTMIND study

August 10, 2026

Top Categories

Cellular Therapy

76

Leukemia

122

Lymphoma

138

Multiple Myeloma

118

Myelodysplastic Syndromes

44

Myeloproliferative Neoplasms

35

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Saad Usmani, MD

Cellular Therapy

Saad Usmani, MD

Leukemia

Saad Usmani, MD

Lymphoma

Saad Usmani, MD

Multiple Myeloma

Saad Usmani, MD

Myelodysplastic Syndromes

Saad Usmani, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

FDA

FDA grants accelerated approval to iberdomide combo in multiple myeloma

cancer cells

Post-transplantation outcomes have improved for Hodgkin lymphoma

Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.